§ Federal grant opportunity · HT942526OCRPOCCTAECI
DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award
Defense Health Agency Contracting Activity - DHACA is accepting applications for DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award. The deadline is October 1, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Application deadline
- October 1, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526OCRPOCCTAECI
Program overview
Summary: Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for ovarian cancer. The OCCTA, through its Leadership, provides for professional and leadership development of the ECIs to include skills and competencies needed to execute clinical trials, providing intensive mentoring, national networking, collaborations, and a peer group for junior clinical trialists. The OCCTA will bring together established investigators (the Academy Dean and Assistant Dean), established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly productive clinical trials in ovarian cancer. Distinctive Features: Research funded under this FY26 funding opportunity will support translational research and small-scale, early-phase clinical trials in ovarian cancer. Preliminary data are required, however, these data do not necessarily need to be derived from the ovarian cancer research field. The ECI must be within 12 years of their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent at the time of full application submission deadline. The ECI must commit no less than 25% effort to this award and/or OCCTA activities for the first two years. The Designated Mentor must be a clinical trialist with a strong record of mentoring and training early-career investigators.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Defense Health Agency Contracting Activity - DHACA.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 1, 2026, allowing time for registration and validation.
Related grant opportunities
- Institute of Education Sciences (IES): National Center for Special Education Research (NCSER): Using Longitudinal Data to Support State Education Policymaking in Special Education, Assistance Listing Number (ALN) 84.324S
- DoW, Ovarian Cancer, Investigator-Initiated Research Award
- In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
- Institute of Education Sciences (IES): National Center for Education Research (NCER): Research Training Programs in The Education Sciences, Assistance Listing Number (ALN) 84.305B
- EDU Core Research (ECR:Core)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.